J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.BO)

INR 1941.8

(4.63%)

Market Cap (In INR)

301.97 Billion

Revenue (In INR)

34.84 Billion

Net Income (In INR)

5.52 Billion

Avg. Volume

7007.00

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1434.5-2029.0
PE
-
EPS
-
Beta Value
-0.016
ISIN
INE572A01036
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Nikhil Ashokkumar Chopra
Employee Count
-
Website
https://www.jbpharma.com
Ipo Date
2001-12-11
Details
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, dimethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. The company provides its services in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.